NK cell destiny after haploSCT with PT-Cy.

about

NK cell destiny after haploSCT with PT-Cy.

Item

http://www.wikidata.org/entity/Q50077346

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

NK cell destiny after haploSCT with PT-Cy.

@en

NK cell destiny after haploSCT with PT-Cy.

@nl

type

Item

label

NK cell destiny after haploSCT with PT-Cy.

@en

NK cell destiny after haploSCT with PT-Cy.

@nl

prefLabel

NK cell destiny after haploSCT with PT-Cy.

@en

NK cell destiny after haploSCT with PT-Cy.

@nl

P1476

NK cell destiny after haploSCT with PT-Cy.

@en

P2093

Amnon Peled

http://www.w3.org/2001/XMLSchema#string

Arnon Nagler

http://www.w3.org/2001/XMLSchema#string

P2860

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Overview of the progress on haploidentical hematopoietic transplantation.

Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation.

A review of infectious complications after haploidentical hematopoietic stem cell transplantations.

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.

Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

P304

161-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-10-811117

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29326351

http://www.w3.org/2001/XMLSchema#string

P932

5757679

http://www.w3.org/2001/XMLSchema#string